CannabisNewsBreaks

MondayApr 27, 2020 9:48 am

CannabisNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Releases Update on Timing of Annual Filings

Plus Products (CSE: PLUS) (OTCQX: PLPRF) on Friday announced that, as a result of the COVID-19 pandemic, it will be relying on the coordinated relief provided by the securities regulators, which consists of a 45-day extension for certain periodic filings, as announced by the Canadian Securities Administrators (“CSA“) on March 18, 2020. According to the update, Plus Products will rely on this relief with respect to the filing of its annual financial statements, management’s discussion and analysis, and related officer certificates for its financial year ended December 31, 2019. The Company will provide a further update concerning the exact timing…

Continue Reading

FridayApr 24, 2020 9:54 am

CannabisNewsBreaks – SinglePoint, Inc. (SING) CEO Discusses Finding Opportunity in Chaotic Times on MoneyTV with Donald Baillargeon

SinglePoint (OTCQB: SING) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally syndicated program covers money-focused topics, featuring various companies and in-depth interviews with CEOs and executives that offer insights into operations and future outlooks. MoneyTV is viewed in over 200 million households in more than 75 countries. Among other highlights from this week’s program, SinglePoint CEO Greg Lambrecht discussed finding opportunity in chaotic times. Discussing the impacts of covid-19, Lambrecht stated, “It forced the company to go virtual. We’ve had our phone operators set up meetings on GoToMeeting and, because of that, we’ve expanded from…

Continue Reading

ThursdayApr 23, 2020 11:38 am

CannabisNewsBreaks – Cannabis Strategic Ventures, Inc. (NUGS) Announces Sharp Expansion in Production Capacity at the Farm

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. cannabis marketplace, today announced that it has increased the total cannabis production capacity at NUGS Farm (the “Farm”) by 88% to 150% as a result of recent management decisions and production upgrades. According to the update, the company expects to produce between 1,500 pounds and 2,000 pounds of cannabis product over the next 45-60 days, and similar amounts of product over subsequent 45-60 day periods. “We have sharply expanded our production capacity to take advantage of an extremely advantageous context,” Cannabis Strategic Ventures CEO Simon Yu said in the…

Continue Reading

ThursdayApr 23, 2020 10:19 am

CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Commences Trading on the OTCQB Venture Market

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, today announced that its common shares have graduated from the OTC Pink Open Market to the OTCQB Venture Market (the “OTCQB”), a U.S. trading platform operated by the OTC Markets Group. Effective immediately, Champignon Brands will commence trading on the OTCQB under the ticker symbol “SHRMF.” Champignon’s common shares will continue to trade under the ticker symbol “SHRM” on the Canadian Securities Exchange as…

Continue Reading

ThursdayApr 23, 2020 10:10 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Announces Notice of Allowance for New Patent, Issuance of Stock Options Under Equity Incentive Plan

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced its receipt of a Notice of Allowance from the United States Patent and Trademark Office ("USPTO") for a new patent. According to the update, the new patent provides additional claims that protect the use of its DehydraTECH(TM) technology together with cannabinoids, nicotine, nonsteroidal anti-inflammatory drugs, or vitamins in mix and serve beverage formats. This patent, with application number 16/497,920 under the title "Food and Beverage Compositions Infused With Lipophilic Active Agents and Methods of Use Thereof," signifies another addition to Lexaria's first patent family, under…

Continue Reading

WednesdayApr 22, 2020 11:59 am

CannabisNewsBreaks – The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) Announces Private Placement, Date for Release of Q4 Earnings

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) on Tuesday announced a non-brokered private placement for gross proceeds of C$20,000,000, with, at the company’s discretion, the ability to upsize the amount to an aggregate gross proceeds of C$25,000,000. According to the update, the company expects to use the proceeds of the Offering for general working capital purposes. “Despite the challenging capital markets environment, we are extremely fortunate to announce this financing and to have continued support from management and insiders who have been instrumental in Flowr’s founding, strategic direction and financing since inception,” Flowr’s CEO Vinay Tolia stated in the news…

Continue Reading

WednesdayApr 22, 2020 10:13 am

CannabisNewsBreaks – Cannabis Global, Inc. (MCTC) and Sugarmade, Inc.’s (SGMD) BudCars Enter License Agreement for Production of Super-Premium Edibles for the California Marketplace

Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, today announced the licensing of several patent-pending technologies to Sugarmade’s (OTCQB: SGMD) Sacramento-based BudCars Cannabis Delivery Service for use in cannabis edibles for the regulated California marketplace. Under the agreement, Cannabis Global will license its unique cannabinoid infusion technologies to BudCars for the production of super-premium, highly bioavailable cannabis edibles. “We have developed and have pending patents on several technologies that not only make the production of cannabis edibles less expensive but also improve product quality.  While we are rolling out our own…

Continue Reading

TuesdayApr 21, 2020 12:21 pm

CannabisNewsBreaks – Kanvas(TM) Announces Vapetelligence(TM) Lite and Vapetelligence(TM) Enterprise Platforms – Taking Brand Ownership and End User Experience to New High

Kanvas(TM), creator of innovative solutions designed to elevate the user experience for legal cannabis and cannabidiol (“CBD”) consumers, on Monday announced the availability of the Vapetelligence™ Lite and Vapetelligence™ Enterprise smart pod customization platforms. According to the update, the platforms offer cannabis and CBD brands web-based, on-demand thermal profile creation and pod programming. “Until now, there’s never been a solution from hardware makers for brands to own the customization experience through on-site programming and testing,” Kanvas CEO Andy Fathollahi stated in the news release. “The Vapetelligence(TM) Lite and Vapetelligence(TM) Enterprise platforms are an unprecedented partnership of software and hardware powered…

Continue Reading

TuesdayApr 21, 2020 10:20 am

CannabisNewsBreaks – Cannabis Global, Inc. (MCTC) Announces New Line of Cannabinoid Beverage Infusion Technologies and Industry’s First THC-V Tea and Coffee Products

Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, today announced a new line of cannabinoid beverage infusion technologies and the industry's first Tetrahydrocannabivarin (“THC-V”) tea and coffee products. According to the update, the Company plans to begin marketing both the infusion technologies and the tea and coffee products beginning May 1, 2020. "We have completed our product development into combining THC-V and other rare cannabinoids into infusion substrates, which can then be easily added to virtually any beverage or into many foods,” Cannabis Global CEO Arman Tabatabaei said in the news…

Continue Reading

TuesdayApr 21, 2020 9:46 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Files New Patent Application for DehydraTECH Technology in Delivery of Antiviral Drugs

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced that it has filed an important new patent application in the United States describing the use of its DehydraTECH(TM) technology for the delivery of antiviral drugs. According to the update, the technology would potentially be used to improve treatment options for viral infectious diseases including COVID-19, MERS, SARS, influenza, herpes, hepatitis and AIDS. "Lexaria's proprietary drug delivery platform has already proven its effectiveness in the oral delivery of other lipophilic drugs such as nicotine, cannabinoids, and more, with multi-fold increases in both the rate…

Continue Reading